Hims & Hers (HIMS), the millennial-skewed telehealth company, saw its stock tumble nearly 9% on Tuesday, as the company braces for big regulatory shifts in the weight-loss drug industry.
Read more...
Read More Details
Finally We wish PressBee provided you with enough information of ( Hims & Hers stock tumbles as the FDA issues a warning about 'unapproved' weight loss drugs )
Also on site :
- Men have hundreds more saved in ‘rainy day’ funds than women, research indicates
- Trump announces U.S.-China trade talks in London
- China consumer prices slump again, deepening deflation worries as demand stays weak